Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Myles D. Greenberg | M | 56 |
Alucent Biomedical Inc.
Alucent Biomedical Inc. Miscellaneous Commercial ServicesCommercial Services Alucent Biomedical Inc. operates as a biomedical company. It focuses on transforming the way vascular disease is treated by which natural vascular scaffolding (NVS) is a breakthrough technology developed to address the unmet need of patients with difficult-to-treat peripheral artery disease (PAD). The company is headquartered in Salt Lake City, UT. | - |
James Corbett | M | 65 |
Alucent Biomedical Inc.
Alucent Biomedical Inc. Miscellaneous Commercial ServicesCommercial Services Alucent Biomedical Inc. operates as a biomedical company. It focuses on transforming the way vascular disease is treated by which natural vascular scaffolding (NVS) is a breakthrough technology developed to address the unmet need of patients with difficult-to-treat peripheral artery disease (PAD). The company is headquartered in Salt Lake City, UT. | - |
Daniel Pelak | M | 72 |
Alucent Biomedical Inc.
Alucent Biomedical Inc. Miscellaneous Commercial ServicesCommercial Services Alucent Biomedical Inc. operates as a biomedical company. It focuses on transforming the way vascular disease is treated by which natural vascular scaffolding (NVS) is a breakthrough technology developed to address the unmet need of patients with difficult-to-treat peripheral artery disease (PAD). The company is headquartered in Salt Lake City, UT. | 6 years |
Pat Costello | M | - |
Alucent Biomedical Inc.
Alucent Biomedical Inc. Miscellaneous Commercial ServicesCommercial Services Alucent Biomedical Inc. operates as a biomedical company. It focuses on transforming the way vascular disease is treated by which natural vascular scaffolding (NVS) is a breakthrough technology developed to address the unmet need of patients with difficult-to-treat peripheral artery disease (PAD). The company is headquartered in Salt Lake City, UT. | - |
David Flicek | M | - |
Alucent Biomedical Inc.
Alucent Biomedical Inc. Miscellaneous Commercial ServicesCommercial Services Alucent Biomedical Inc. operates as a biomedical company. It focuses on transforming the way vascular disease is treated by which natural vascular scaffolding (NVS) is a breakthrough technology developed to address the unmet need of patients with difficult-to-treat peripheral artery disease (PAD). The company is headquartered in Salt Lake City, UT. | - |
Julie Lautt | F | - |
Alucent Biomedical Inc.
Alucent Biomedical Inc. Miscellaneous Commercial ServicesCommercial Services Alucent Biomedical Inc. operates as a biomedical company. It focuses on transforming the way vascular disease is treated by which natural vascular scaffolding (NVS) is a breakthrough technology developed to address the unmet need of patients with difficult-to-treat peripheral artery disease (PAD). The company is headquartered in Salt Lake City, UT. | - |
Connections Chart
Multi-company connection
Statistics
Country | Connections | % of total |
---|---|---|
United States | 6 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Ryan Hansen
- Personal Network